STOCK TITAN
  1. Home
  2. PRDS

Pardes Biosciences Stock Price, News & Analysis

PRDS NASDAQ

Company Description

Pardes Biosciences (NASDAQ: PRDS) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector.

PRDS stock has declined 100.0% over the past year.

This page provides a comprehensive overview of PRDS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-100%
Performance 1 year
$0.0
Market Cap
62.0M
Shares outstanding

Pardes Biosciences (PRDS) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All
0.00%

Pardes Biosciences Announces Closing of Tender Offer

0.00%

MediPacific Offering $2.13 Per Share Plus One Contingent Value Right Per Share in Tender Offer for Pardes Biosciences

+0.95%

MediPacific Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Pardes Biosciences Shares

+15.14%

Pardes Biosciences Enters into Agreement to be Acquired by MediPacific, Inc. for between $2.02 and $2.19 in Cash per Share Plus Contingent Value Rights

acquisition
+0.53%

Pardes Biosciences Reports First Quarter 2023 Financial Results

earnings
+8.33%

Pardes Biosciences Announces Top-line Results from Phase 2 Trial Evaluating Pomotrelvir for the Treatment of COVID-19

clinical trial covid-19

Pardes Biosciences has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, earnings, clinical trial, covid-19, conferences. View all PRDS news →

SEC Filings

View All

No SEC filings available for PRDS.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

PRDS Company Profile & Sector Positioning

Pardes Biosciences (PRDS) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.